loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r1_cep_2011_325___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CAMBREX KARLSKOGA AB Karlskoga SE (1)

filter

01 Lidocaine hydrochloride monohydrate (1)

filter

01 U.S.A (1)

filter

01 Valid (1)

URL Supplier Web Content
R1-CEP 2011-325 - Rev 02
Valid
Chemical
2021-06-22
227
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-325 - Rev 02 of Cambrex Karlskoga Ab Karlskoga Se

Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-325 - Rev 02 of Cambrex Karlskoga Ab Karlskoga Se 1

20

Cambrex Karlskoga Ab Karlskoga Se, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.

One of their significant offerings is Lidocaine hydrochloride monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-325 - Rev 02

This Chemical Type CEP, issued on June 22, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 227 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY